The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BERNIE: Open-label, randomized, phase II study of bevacizumab plus chemotherapy in pediatric metastatic rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS).
 
Julia C. Chisholm
Consulting or Advisory Role - Merck Sharp & Dohme; Proacta
 
Johannes H. Merks
Consulting or Advisory Role - Proacta
 
Michela Casanova
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Loxo; Proacta
 
Gianni Bisogno
Consulting or Advisory Role - Loxo
Research Funding - Indena (Inst)
 
Daniel Orbach
No Relationships to Disclose
 
Jean-Claude Gentet
No Relationships to Disclose
 
Anne-Sophie Thomassin Defachelles
No Relationships to Disclose
 
Pascal B. Chastagner
No Relationships to Disclose
 
Steve Lowis
No Relationships to Disclose
 
Milind Ronghe
No Relationships to Disclose
 
Kieran McHugh
No Relationships to Disclose
 
Rick R. van Rijn
Research Funding - Proacta (Inst)
 
Magalie Hilton
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
Jeanette Bachir
Employment - Proacta
 
Sabine Fürst-Recktenwald
Employment - Proacta
 
Birgit Geoerger
No Relationships to Disclose
 
Odile Oberlin
No Relationships to Disclose